Dow Jones

39,671.04

0.00%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

GDT

Guidant (GDT)

Guidant Corp

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:GDT

1 2 3 4 5 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
21/04/2006	12:02	PR Newswire (US)	Boston Scientific Completes Combination with Guidant	NYSE:GDT	Guidant Corp
21/04/2006	08:12	PR Newswire (US)	Abbott Completes Acquisition of Guidant Vascular Business	NYSE:GDT	Guidant Corp
20/04/2006	08:00	PR Newswire (US)	Boston Scientific Receives FTC Antitrust Approval for its Combination with Guidant	NYSE:GDT	Guidant Corp
11/04/2006	18:05	PR Newswire (US)	Standard & Poor's Announces Changes to U.S. Indices	NYSE:GDT	Guidant Corp
11/04/2006	12:59	PR Newswire (US)	Boston Scientific Receives European Commission's Antitrust Clearance for Guidant Transaction	NYSE:GDT	Guidant Corp
05/04/2006	16:34	PR Newswire (US)	Boston Scientific Signs Agreement Resolving All Outstanding Antitrust Issues With FTC Staff on Guidant Transaction	NYSE:GDT	Guidant Corp
05/04/2006	16:25	Business Wire	Guidant Announces Preliminary First Quarter 2006 Sales	NYSE:GDT	Guidant Corp
31/03/2006	11:03	PR Newswire (US)	Boston Scientific and Guidant Shareholders Each Approve Combination	NYSE:GDT	Guidant Corp
29/03/2006	07:00	Business Wire	Guidant to Temporarily Suspend XIENCE V Supply; Company Expects European Launch of XIENCE V in Third Quarter 2006	NYSE:GDT	Guidant Corp
23/03/2006	17:10	PR Newswire (US)	Boston Scientific Makes Antitrust Commitments To European Commission	NYSE:GDT	Guidant Corp
21/03/2006	06:30	Business Wire	Guidant Receives Independent Panel Report and Recommendations; Panel Chaired by Dr. Myerburg, an Internationally Recognized Lea	NYSE:GDT	Guidant Corp
21/03/2006	06:25	PR Newswire (US)	Independent Panel Commissioned by Guidant Issues Report and Recommendations	NYSE:GDT	Guidant Corp
20/03/2006	08:30	PR Newswire (US)	Institutional Shareholder Services Recommends That Shareholders of Boston Scientific and Guidant Approve Combination	NYSE:GDT	Guidant Corp
17/03/2006	08:00	Business Wire	Guidant Announces Enrollment of First Patient in Landmark Carotid Artery Stenting Study; 10,000-Patient Study Aims to Further U	NYSE:GDT	Guidant Corp
16/03/2006	13:30	Business Wire	Guidant to Expand Southern California Facilities; Drug Eluting and Carotid Stents, Emerging Therapies Drive Expansion	NYSE:GDT	Guidant Corp
15/03/2006	13:29	Business Wire	Guidant Completes Enrollment in Randomized U.S. Portion of Drug Eluting Stent Pivotal Trial; Large-Scale Trial Evaluating Safet	NYSE:GDT	Guidant Corp
14/03/2006	14:58	Business Wire	Guidant Announces Updated and Positive Results of Real-World Carotid Artery Stenting Study; Results from 2,500 Patients Suggest	NYSE:GDT	Guidant Corp
13/03/2006	08:00	Business Wire	Guidant Initiates Voluntary Worldwide Physician Communication Regarding Implantable Cardiac Defibrillators	NYSE:GDT	Guidant Corp
10/03/2006	12:00	Business Wire	R. Frederick McCoy, Jr., Elects Early Retirement from Guidant	NYSE:GDT	Guidant Corp
09/03/2006	11:00	Business Wire	Guidant Launches Innovative Cobalt Chromium Biliary Stent; RX HERCULINK ELITE Biliary Stent System Provides Superb Deliverabili	NYSE:GDT	Guidant Corp
09/03/2006	08:02	Business Wire	Guidant Announces Enrollment of First Patient in Clinical Trial of the World's First Fully Bioabsorbable Drug Eluting Coronary	NYSE:GDT	Guidant Corp
06/03/2006	10:14	PR Newswire (US)	Seven Summits Research Releases Comments on GM, RIMM, CELG, GDT, and LEXR	NYSE:GDT	Guidant Corp
02/03/2006	17:11	PR Newswire (US)	Boston Scientific and Guidant Proposed Merger Registration Statement Declared Effective	NYSE:GDT	Guidant Corp
23/02/2006	11:09	PR Newswire (US)	Boston Scientific Files Notification with European Commission	NYSE:GDT	Guidant Corp
23/02/2006	07:31	Business Wire	Guidant Announces Completion of FDA Inspection of St. Paul Facilities; Company Reports One Inspection Observation and Reiterates	NYSE:GDT	Guidant Corp
07/02/2006	07:00	Business Wire	Theregen Announces Equity Investment from Guidant Corporation to Develop Anginera(TM) Epicardial Patch	NYSE:GDT	Guidant Corp
06/02/2006	09:32	PR Newswire (US)	Boston Scientific Files Hart-Scott-Rodino Pre-Merger Notification	NYSE:GDT	Guidant Corp
30/01/2006	13:02	Business Wire	Guidant Receives European Approval for Drug Eluting Coronary Stent; Company Achieves CE Mark Approval Ahead of Schedule; XIENCE	NYSE:GDT	Guidant Corp
27/01/2006	07:30	Business Wire	Guidant Reports Fourth Quarter Sales of $828 Million; Full Year 2005 Sales of $3.55 Billion; Earnings from Continuing Operations	NYSE:GDT	Guidant Corp
25/01/2006	06:02	PR Newswire (US)	Boston Scientific and Guidant Announce Signing of Merger Agreement Valued at $27 Billion	NYSE:GDT	Guidant Corp